{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:54:43Z","timestamp":1793717683787,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59579-4","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T13:34:19Z","timestamp":1747143259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-3234","authenticated-orcid":false,"given":"Xiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaotian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-6478","authenticated-orcid":false,"given":"Yingchun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-5641","authenticated-orcid":false,"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-9046","authenticated-orcid":false,"given":"Jingke","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"59579_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrrheum.2009.140","volume":"5","author":"T Uhlig","year":"2009","unstructured":"Uhlig, T. & Kvien, T. K. Is rheumatoid arthritis really getting less severe? Nat. Rev. Rheumatol. 5, 461\u2013464 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/annrheumdis-2019-216243","volume":"79","author":"P-H Hsieh","year":"2020","unstructured":"Hsieh, P.-H. et al. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann. Rheum. Dis. 79, 771\u2013777 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","volume":"78","author":"S Safiri","year":"2019","unstructured":"Safiri, S. et al. Global, regional and national burden of rheumatoid arthritis 1990\u20132017: a systematic analysis of the Global Burden of Disease study 2017. Ann. Rheum. Dis. 78, 1463\u20131471 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","volume":"8","author":"A Willemze","year":"2012","unstructured":"Willemze, A., Trouw, L. A., Toes, R. E. M. & Huizinga, T. W. J. The influence of ACPA status and characteristics on the course of RA. Nat. Rev. Rheumatol. 8, 144\u2013152 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR5","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1021\/acsnano.2c09127","volume":"17","author":"F Zhou","year":"2023","unstructured":"Zhou, F. et al. Redox homeostasis strategy for inflammatory macrophage reprogramming in rheumatoid arthritis based on ceria oxide nanozyme-complexed biopolymeric micelles. ACS Nano 17, 4358\u20134372 (2023).","journal-title":"ACS Nano"},{"key":"59579_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36468-2","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Remodeling articular immune homeostasis with an efferocytosis-informed nanoimitator mitigates rheumatoid arthritis in mice. Nat. Commun. 14, 817 (2023).","journal-title":"Nat. Commun."},{"key":"59579_CR7","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","volume":"55","author":"S Alivernini","year":"2022","unstructured":"Alivernini, S., Firestein, G. S. & McInnes, I. B. The pathogenesis of rheumatoid arthritis. Immunity 55, 2255\u20132270 (2022).","journal-title":"Immunity"},{"key":"59579_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","volume":"13","author":"AI Catrina","year":"2017","unstructured":"Catrina, A. I., Svensson, C. I., Malmstr\u00f6m, V., Schett, G. & Klareskog, L. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 79\u201386 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","volume":"21","author":"A Salhotra","year":"2020","unstructured":"Salhotra, A., Shah, H. N., Levi, B. & Longaker, M. T. Mechanisms of bone development and repair. Nat. Rev. Mol. Cell Biol. 21, 696\u2013711 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59579_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu, N. & Takayanagi, H. Mechanisms of joint destruction in rheumatoid arthritis-immune cell\u2013fibroblast\u2013bone interactions. Nat. Rev. Rheumatol. 18, 415\u2013429 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrrheum.2009.182","volume":"5","author":"RF van Vollenhoven","year":"2009","unstructured":"van Vollenhoven, R. F. Treatment of rheumatoid arthritis: state of the art 2009. Nat. Rev. Rheumatol. 5, 531\u2013541 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrrheum.2016.34","volume":"12","author":"M Hudson","year":"2016","unstructured":"Hudson, M., Tascilar, K. & Suissa, S. Comparative effectiveness research with administrative health data in rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 358\u2013366 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59579_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","volume":"12","author":"F Atzeni","year":"2013","unstructured":"Atzeni, F. et al. Different effects of biological drugs in rheumatoid arthritis. Autoimmun. Rev. 12, 575\u2013579 (2013).","journal-title":"Autoimmun. Rev."},{"key":"59579_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/ard.59.11.841","volume":"59","author":"FC Breedveld","year":"2000","unstructured":"Breedveld, F. C. & Dayer, J. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann. Rheum. Dis. 59, 841\u2013849 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102425","volume":"110","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S. Insights into the treatment of rheumatoid arthritis: a paradigm in medicine. J. Autoimmun. 110, 102425 (2020).","journal-title":"J. Autoimmun."},{"key":"59579_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/BOR.0000000000000789","volume":"33","author":"KD Wysham","year":"2021","unstructured":"Wysham, K. D., Baker, J. F. & Shoback, D. M. Osteoporosis and fractures in rheumatoid arthritis. Curr. Opin. Rheumatol. 33, 270\u2013276 (2021).","journal-title":"Curr. Opin. Rheumatol."},{"key":"59579_CR17","doi-asserted-by":"publisher","first-page":"e15055","DOI":"10.1111\/1756-185X.15055","volume":"27","author":"Y-J Su","year":"2024","unstructured":"Su, Y.-J., Lin, C.-Y. & Hsu, C.-Y. Analyzing the risk of osteoporosis and fracture in rheumatoid arthritis patients who have been treated with various biologics. Int. J. Rheum. Dis. 27, e15055 (2024).","journal-title":"Int. J. Rheum. Dis."},{"key":"59579_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","volume":"78","author":"T Takeuchi","year":"2019","unstructured":"Takeuchi, T. et al. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Ann. Rheum. Dis. 78, 899\u2013907 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41587-022-01249-7","volume":"40","author":"BW Jester","year":"2022","unstructured":"Jester, B. W. et al. Development of spirulina for the manufacture and oral delivery of protein therapeutics. Nat. Biotechnol. 40, 956\u2013964 (2022).","journal-title":"Nat. Biotechnol."},{"key":"59579_CR20","doi-asserted-by":"publisher","first-page":"1910395","DOI":"10.1002\/adfm.201910395","volume":"30","author":"D Zhong","year":"2020","unstructured":"Zhong, D., Li, W., Qi, Y., He, J. & Zhou, M. Photosynthetic biohybrid nanoswimmers system to alleviate tumor hypoxia for FL\/PA\/MR imaging-guided enhanced radio-photodynamic synergetic therapy. Adv. Funct. Mater. 30, 1910395 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"59579_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cmi.2010.76","volume":"8","author":"C Selmi","year":"2011","unstructured":"Selmi, C. et al. The effects of Spirulina on anemia and immune function in senior citizens. Cell. Mol. Immunol. 8, 248\u2013254 (2011).","journal-title":"Cell. Mol. Immunol."},{"key":"59579_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1039\/D2NH00572G","volume":"8","author":"Q-W Chen","year":"2023","unstructured":"Chen, Q.-W., Cao, M.-W., Qiao, J.-Y., Li, Q.-R. & Zhang, X.-Z. Integrated cascade catalysis of microalgal bioenzyme and inorganic nanozyme for anti-inflammation therapy. Nanoscale Horiz. 8, 489\u2013498 (2023).","journal-title":"Nanoscale Horiz."},{"key":"59579_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202000819","volume":"16","author":"D Zhong","year":"2020","unstructured":"Zhong, D., Zhang, D., Xie, T. & Zhou, M. Biodegradable microalgae-based carriers for targeted delivery and imaging-guided therapy toward lung metastasis of breast cancer. Small 16, e2000819 (2020).","journal-title":"Small"},{"key":"59579_CR24","doi-asserted-by":"publisher","first-page":"2300833","DOI":"10.1002\/adfm.202300833","volume":"33","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Engineered oxygen factories synergize with STING agonist to remodel tumor microenvironment for cancer immunotherapy. Adv. Funct. Mater. 33, 2300833 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"59579_CR25","doi-asserted-by":"publisher","first-page":"3247528","DOI":"10.1155\/2017\/3247528","volume":"2017","author":"A Finamore","year":"2017","unstructured":"Finamore, A., Palmery, M., Bensehaila, S. & Peluso, I. Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly Spirulina. Oxid. Med. Cell. Longev. 2017, 3247528 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"59579_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","volume":"10","author":"H Motohashi","year":"2004","unstructured":"Motohashi, H. & Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549\u2013557 (2004).","journal-title":"Trends Mol. Med."},{"key":"59579_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2024.03.005","volume":"36","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron\u2013ornithine axis. Cell Metab. 36, 1\u201317 (2024).","journal-title":"Cell Metab."},{"key":"59579_CR28","doi-asserted-by":"publisher","first-page":"e00099","DOI":"10.1128\/MCB.00099-20","volume":"40","author":"L Baird","year":"2020","unstructured":"Baird, L. & Yamamoto, M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol. Cell. Biol. 40, e00099\u201320 (2020).","journal-title":"Mol. Cell. Biol."},{"key":"59579_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cmet.2012.12.002","volume":"17","author":"SH Bae","year":"2013","unstructured":"Bae, S. H. et al. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab. 17, 73\u201384 (2013).","journal-title":"Cell Metab."},{"key":"59579_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39412-6","volume":"14","author":"C Cai","year":"2023","unstructured":"Cai, C. et al. USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat. Commun. 14, 3648 (2023).","journal-title":"Nat. Commun."},{"key":"59579_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-019-0330-9","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Luo, J., Chen, X., Liu, W. & Chen, T. Cell membrane coating technology: a promising strategy for biomedical applications. Nano-Micro Lett. 11, 100 (2019).","journal-title":"Nano-Micro Lett."},{"key":"59579_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11390-8","volume":"10","author":"Z Cao","year":"2019","unstructured":"Cao, Z., Cheng, S., Wang, X., Pang, Y. & Liu, J. Camouflaging bacteria by wrapping with cell membranes. Nat. Commun. 10, 3452 (2019).","journal-title":"Nat. Commun."},{"key":"59579_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26052-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat. Commun. 12, 5726 (2021).","journal-title":"Nat. Commun."},{"key":"59579_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.mattod.2018.04.001","volume":"21","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Rapid continuous 3D printing of customizable peripheral nerve guidance conduits. Mater. Today 21, 951\u2013959 (2018).","journal-title":"Mater. Today"},{"key":"59579_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304333","volume":"36","author":"MJ Shin","year":"2024","unstructured":"Shin, M. J. et al. Inflammation-targeting mesenchymal stem cells combined with photothermal treatment attenuate severe joint inflammation. Adv. Mater. 36, e2304333 (2024).","journal-title":"Adv. Mater."},{"key":"59579_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.03.022","volume":"206","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials 206, 87\u2013100 (2019).","journal-title":"Biomaterials"},{"key":"59579_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202108817","volume":"34","author":"M Hou","year":"2022","unstructured":"Hou, M. et al. Immuno-engineered nanodecoys for the multi-target anti-inflammatory treatment of autoimmune diseases. Adv. Mater. 34, e2108817 (2022).","journal-title":"Adv. Mater."},{"key":"59579_CR38","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41565-023-01523-y","volume":"18","author":"S Koo","year":"2023","unstructured":"Koo, S. et al. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nat. Nanotechnol. 18, 1502\u20131514 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"59579_CR39","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1039\/D2BM02072F","volume":"11","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy. Biomater. Sci. 11, 2211\u20132220 (2023).","journal-title":"Biomater. Sci."},{"key":"59579_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36625-7","volume":"14","author":"H Han","year":"2023","unstructured":"Han, H., Xing, J., Chen, W., Jia, J. & Li, Q. Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats. Nat. Commun. 14, 944 (2023).","journal-title":"Nat. Commun."},{"key":"59579_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211977120","volume":"120","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis. Proc. Natl Acad. Sci. USA 120, e2211977120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59579_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202206821","volume":"35","author":"Y Wei","year":"2023","unstructured":"Wei, Y. et al. Oral delivery of siRNA using fluorinated, small-sized nanocapsules toward anti-inflammation treatment. Adv. Mater. 35, e2206821 (2023).","journal-title":"Adv. Mater."},{"key":"59579_CR43","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1039\/D3BM00911D","volume":"11","author":"S Meng","year":"2023","unstructured":"Meng, S. et al. Surface-decorated nanoliposomal leonurine targets activated fibroblast-like synoviocytes for efficient rheumatoid arthritis therapy. Biomater. Sci. 11, 7099\u20137113 (2023).","journal-title":"Biomater. Sci."},{"key":"59579_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202310061","volume":"62","author":"J Yang","year":"2023","unstructured":"Yang, J., Yang, B. & Shi, J. A nanomedicine-enabled ion-exchange strategy for enhancing curcumin-based rheumatoid arthritis therapy. Angew. Chem. Int. Ed. 62, e202310061 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"59579_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102068","volume":"54","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Macrophage-hitchhiking interleukin-10 plasmid DNA delivery system modulates rheumatoid arthritis microenvironment via the re-polarization of macrophages. Nano Today 54, 102068 (2024).","journal-title":"Nano Today"},{"key":"59579_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202302503","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. A Targeted exosome therapeutic confers both CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis. Adv. Mater. 35, e2302503 (2023).","journal-title":"Adv. Mater."},{"key":"59579_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/ard-2022-223626","volume":"83","author":"S Cao","year":"2024","unstructured":"Cao, S. et al. l-arginine metabolism inhibits arthritis and inflammatory bone loss. Ann. Rheum. Dis. 83, 72\u201387 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR48","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1136\/ard-2023-224116","volume":"82","author":"M \u00d8stergaard","year":"2023","unstructured":"\u00d8stergaard, M. et al. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial. Ann. Rheum. Dis. 82, 1286\u20131295 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"59579_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070856","volume":"384","author":"P Brown","year":"2024","unstructured":"Brown, P., Pratt, A. G. & Hyrich, K. L. Therapeutic advances in rheumatoid arthritis. Br. Med. J. 384, e070856 (2024).","journal-title":"Br. Med. J."},{"key":"59579_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107177","volume":"34","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Biomembrane-functionalized micromotors: biocompatible active devices for diverse biomedical applications. Adv. Mater. 34, e2107177 (2022).","journal-title":"Adv. Mater."},{"key":"59579_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202006484","volume":"17","author":"F Oroojalian","year":"2021","unstructured":"Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A. & Shahbazi, M.-A. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small 17, e2006484 (2021).","journal-title":"Small"},{"key":"59579_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33\u201348 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"59579_CR53","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1021\/acsnano.3c00041","volume":"17","author":"C Gao","year":"2023","unstructured":"Gao, C. et al. Conjugation of macrophage-mimetic microalgae and liposome for antitumor sonodynamic immunotherapy via hypoxia alleviation and autophagy inhibition. ACS Nano 17, 4034\u20134049 (2023).","journal-title":"ACS Nano"},{"key":"59579_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202208781","volume":"35","author":"N Su","year":"2023","unstructured":"Su, N. et al. Stem cell membrane-coated microribbon scaffolds induce regenerative innate and adaptive immune responses in a critical-size cranial bone defect model. Adv. Mater. 35, e2208781 (2023).","journal-title":"Adv. Mater."},{"key":"59579_CR55","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"59579_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303432","volume":"35","author":"J Mei","year":"2023","unstructured":"Mei, J. et al. Biofilm microenvironment-responsive self-assembly nanoreactors for all-stage biofilm associated infection through bacterial cuproptosis-like death and macrophage re-rousing. Adv. Mater. 35, e2303432 (2023).","journal-title":"Adv. Mater."},{"key":"59579_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306143","volume":"11","author":"S Li","year":"2024","unstructured":"Li, S. et al. A novel cargo delivery system-AnCar-ExoLaIMTS ameliorates arthritis via specifically targeting pro-inflammatory macrophages. Adv. Sci. 11, e2306143 (2024).","journal-title":"Adv. Sci."},{"key":"59579_CR58","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1021\/acsnano.3c01502","volume":"17","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Oral microalgae-nano integrated system against radiation-induced injury. ACS Nano 17, 10560\u201310576 (2023).","journal-title":"ACS Nano"},{"key":"59579_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"59579_CR60","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molmed.2023.07.008","volume":"29","author":"S Geertsema","year":"2023","unstructured":"Geertsema, S. et al. The NRF2\/Keap1 pathway as a therapeutic target in inflammatory bowel disease. Trends Mol. Med. 29, 830\u2013842 (2023).","journal-title":"Trends Mol. Med."},{"key":"59579_CR61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies, H., Berndt, C. & Jones, D. P. Oxidative stress. Annu. Rev. Biochem. 86, 715\u2013748 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"59579_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-019-0079-0","volume":"4","author":"SS Athari","year":"2019","unstructured":"Athari, S. S. Targeting cell signaling in allergic asthma. Signal Transduct. Target. Ther. 4, 45 (2019).","journal-title":"Signal Transduct. Target. Ther."},{"key":"59579_CR63","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1021\/acsomega.4c00163","volume":"9","author":"S Saha","year":"2024","unstructured":"Saha, S. An overview of therapeutic targeting of Nrf2 signaling pathway in rheumatoid arthritis. ACS Omega 9, 10049\u201310057 (2024).","journal-title":"ACS Omega"},{"key":"59579_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","volume":"23","author":"JA Wells","year":"2024","unstructured":"Wells, J. A. & Kumru, K. Extracellular targeted protein degradation: an emerging modality for drug discovery. Nat. Rev. Drug Discov. 23, 126\u2013140 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"59579_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6249","volume":"382","author":"G Ahn","year":"2023","unstructured":"Ahn, G. et al. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science 382, eadf6249 (2023).","journal-title":"Science"},{"key":"59579_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207216","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Polydopamine nanoparticles targeting ferroptosis mitigate intervertebral disc degeneration via reactive oxygen species depletion, iron ions chelation, and GPX4 ubiquitination suppression. Adv. Sci. 10, e2207216 (2023).","journal-title":"Adv. Sci."},{"key":"59579_CR67","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","volume":"13","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13, 1182\u20131190 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"59579_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204998","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Regulatory fibroblast-like synoviocytes cell membrane coated nanoparticles: a novel targeted therapy for rheumatoid arthritis. Adv. Sci. 10, e2204998 (2023).","journal-title":"Adv. Sci."},{"key":"59579_CR69","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41590-019-0526-7","volume":"20","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa, T. et al. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nat. Immunol. 20, 1631\u20131643 (2019).","journal-title":"Nat. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59579-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:05:09Z","timestamp":1747148709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59579-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59579"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59579-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4434"}}